[RH(ETA-4-2,5-NORBORNADIENE)(KAPA-2-(3-ISO-PR2P-2-ME2N-INDENE))]-[BF4]
Compound with spectra: 1 NMR
![[RH(ETA-4-2,5-NORBORNADIENE)(KAPA-2-(3-ISO-PR2P-2-ME2N-INDENE))]-[BF4]](/api/compound/ERGIzV8xWYl.png?ph=true&h=300&w=458 "[RH(ETA-4-2,5-NORBORNADIENE)(KAPA-2-(3-ISO-PR2P-2-ME2N-INDENE))]-[BF4]")
| SpectraBase Compound ID | ERGIzV8xWYl |
|---|---|
| InChI | InChI=1S/C17H26NP.C7H4.BF4.Rh/c1-12(2)19(13(3)4)17-15-10-8-7-9-14(15)11-16(17)18(5)6;1-2-7-4-3-6(1)5-7;2-1(3,4)5;/h7-10,12-13H,11H2,1-6H3;6-7H,5H2;;/q;;-1;/p+1/t;6-,7+;; |
| InChIKey | MDDOOLLMNBZXHL-XDWRCRRRSA-O |
| Mol Weight | 554.2 g/mol |
| Molecular Formula | C24H31BF4NPRh |
| Exact Mass | 554.12782 g/mol |
| Parent InChIKey | HNPJQQSWLNLMDG-DAULDNKOSA-O |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S*,2R*,3S*,3aR*,7aS*)-5,5-(Ethylenedioxy)-2,3-epoxy-1-hydroxy-3a,7,7-trimethyl-3-phenyl-1,3a,4,6,7,7a-hexahydroinden-5-one
Benzo[g]pyridazino[1,2-b]phthalazine-6,13-dione, 2-bromo-1-ethoxy-1,2,3,4-tetrahydro-2,3-dimethyl-, (1.alpha.,2.beta.,3.beta.)-
ENT-1-BETA-ACETOXY-17-HYDROXY-BEYER-15-EN-12-ONE
3,6,10-Trimethyl-8H-difuro[2,3-f : 2',3'-h]-(1)-benzopyran-8-one
1,1-Dimethylethyl 1-[1-(thiophen-2-yl)-1H-indol-3-yl]-3,4-dihydroisoquinoline-2(1H)-carboxylate
N-(4-Fluorophenyl)bis[1]benzothieno[2,3-b:2',3'-e][1,4]thiazine
3-CYANO-PYRROLO-[2,1-F]-[1,6]-NAPHTHHYDRINE-1,2-DICARBOXYLATE
Dimethyl 2-(2-(2-oxobenzo[d]oxazol-3(2H)-yl)quinolin-1(2H)-yl)fumarate
1-allyl-2-imino-10-methyl-3-(phenylsulfonyl)-1,2-dihydro-5H-dipyrido[1,2-a:2,3-d]pyrimidin-5-one
(4a.beta.,8.alpha.,8a.beta.,9.alpha.)-6-(tert-Butyldimethylsiloxy)-9-hydroxy-8-methoxy-3,8a-dimethyl-5,8,8a,9-tetrahydronaphtho[2,3-b]furan-4(4aH)-one
| Title | Journal or Book | Year |
|---|---|---|
| A Catalytically Active, Charge-Neutral Rh(I) Zwitterion Featuring a P,N-Substituted “Naked” Indenide Ligand | Journal of the American Chemical Society | 2003 |